Does Chrysin prevent severe lung damage in Hyperoxia-Induced lung injury Model?
INTERNATIONAL IMMUNOPHARMACOLOGY, vol.99, 2021 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 99
- Publication Date: 2021
- Doi Number: 10.1016/j.intimp.2021.108033
- Journal Name: INTERNATIONAL IMMUNOPHARMACOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, Biotechnology Research Abstracts, CAB Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE, Veterinary Science Database
- Keywords: Bronchopulmonary Dysplasia, Chronic Lung Disease, Chrysin, Newborn, Antioxidant, Antiinflammatory, Hyperoxia-Induced Lung Injury, BRONCHOPULMONARY DYSPLASIA, OXIDATIVE STRESS, INFLAMMATION, PROTECTS, RATS, MICE
- Inonu University Affiliated: Yes
Abstract
Background: Oxidative stress and inflammation play a critical role in the etiopathogenesis of bronchopulmonary dysplasia (BPD). The aim of this study was to evaluate the preventive effect of Chrysin (CH), an antioxidant, antiinflammatory, antiapoptotic and antifibrotic drug, on hyperoxia-induced lung injury in a neonatal rat model.